US6048729A
(en)
*
|
1987-05-01 |
2000-04-11 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
FR2646438B1
(fr)
|
1989-03-20 |
2007-11-02 |
Pasteur Institut |
Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
|
WO1991006666A1
(en)
*
|
1989-11-06 |
1991-05-16 |
Cell Genesys, Inc. |
Production of proteins using homologous recombination
|
US5272071A
(en)
*
|
1989-12-22 |
1993-12-21 |
Applied Research Systems Ars Holding N.V. |
Method for the modification of the expression characteristics of an endogenous gene of a given cell line
|
AU645294B2
(en)
*
|
1989-12-22 |
1994-01-13 |
Merck Serono Sa |
Endogenous gene expression modification with regulatory element
|
GB9028062D0
(en)
*
|
1990-12-24 |
1991-02-13 |
Agricultural & Food Res |
Production of transgenic animals
|
JPH06507550A
(ja)
*
|
1991-05-06 |
1994-09-01 |
セル ジェネシス,インコーポレイティド |
ゲノム性要素を使用する遺伝子の操作および発現
|
WO1992021763A1
(en)
*
|
1991-05-31 |
1992-12-10 |
Genentech, Inc. |
Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
|
AU2515992A
(en)
*
|
1991-08-20 |
1993-03-16 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US6692737B1
(en)
|
1991-11-05 |
2004-02-17 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US6063630A
(en)
|
1991-11-05 |
2000-05-16 |
Transkaryotic Therapies, Inc. |
Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
|
PT101031B
(pt)
*
|
1991-11-05 |
2002-07-31 |
Transkaryotic Therapies Inc |
Processo para o fornecimento de proteinas por terapia genetica
|
US5641670A
(en)
*
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US6054288A
(en)
*
|
1991-11-05 |
2000-04-25 |
Transkaryotic Therapies, Inc. |
In vivo protein production and delivery system for gene therapy
|
US5968502A
(en)
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US20020108136A1
(en)
*
|
1997-03-21 |
2002-08-08 |
Sri |
Transgenic animals produced by homologous sequence targeting
|
WO1993024642A1
(en)
*
|
1992-06-04 |
1993-12-09 |
Exemplar Corporation |
Insertion of heterologous dna outside of known chromosomal genes
|
US6531124B1
(en)
|
1992-07-10 |
2003-03-11 |
Transkaryotic Therapies, Inc. |
In vivo production and delivery of insulinotropin for gene therapy
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
US5733753A
(en)
*
|
1992-12-22 |
1998-03-31 |
Novo Nordisk A/S |
Amplification of genomic DNA by site specific integration of a selectable marker construct
|
DK0695361T4
(da)
|
1993-04-21 |
2010-03-22 |
Univ Edinburgh |
Ekspression af heterologe gener ifølge en målekspressionsprofil
|
US6124439A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockefeller University |
OB polypeptide antibodies and method of making
|
US6350730B1
(en)
|
1994-08-17 |
2002-02-26 |
The Rockefeller University |
OB polypeptides and modified forms as modulators of body weight
|
US6124448A
(en)
*
|
1994-08-17 |
2000-09-26 |
The Rockfeller University |
Nucleic acid primers and probes for the mammalian OB gene
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
US6471956B1
(en)
|
1994-08-17 |
2002-10-29 |
The Rockefeller University |
Ob polypeptides, modified forms and compositions thereto
|
US6001968A
(en)
*
|
1994-08-17 |
1999-12-14 |
The Rockefeller University |
OB polypeptides, modified forms and compositions
|
US6048837A
(en)
*
|
1994-08-17 |
2000-04-11 |
The Rockefeller University |
OB polypeptides as modulators of body weight
|
US5759775A
(en)
|
1994-10-27 |
1998-06-02 |
Genetech, Inc. |
Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
|
US6610296B2
(en)
|
1995-10-26 |
2003-08-26 |
Genentech, Inc. |
Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
|
JP2000503204A
(ja)
|
1996-01-08 |
2000-03-21 |
ジェネンテック インコーポレーテッド |
Wsxレセプター及びリガンド類
|
US7063958B1
(en)
|
1996-01-16 |
2006-06-20 |
The Rockefeller University |
Nucleic acids db, the receptor for leptin
|
US7148004B1
(en)
|
1997-01-16 |
2006-12-12 |
The Rockefeller University |
Oligonucleotides of the OB-R isoforms and methods of diagnosing body weight
|
US7084252B1
(en)
|
1996-01-16 |
2006-08-01 |
The Rockefeller University |
DB, the receptor for leptin
|
US7619079B2
(en)
|
1996-02-14 |
2009-11-17 |
The Rockefeller University |
Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
|
US5792210A
(en)
*
|
1996-06-10 |
1998-08-11 |
Environmental Behavior Modification Inc. |
Electrical tongue stimulator and method for addiction treatment
|
EP0963432A4
(de)
|
1996-08-29 |
2002-11-20 |
Univ California |
Kuz, eine neue familie von metalloproteasen
|
US6566089B1
(en)
*
|
1996-09-04 |
2003-05-20 |
Tularik Inc. |
Cell-based drug screens for regulators of gene expression
|
AU4424597A
(en)
*
|
1996-09-13 |
1998-04-02 |
Novo Nordisk Biotech, Inc. |
Cells having dna insertion mutations which produce altered amounts of a polypeptide
|
JPH10117771A
(ja)
*
|
1996-10-23 |
1998-05-12 |
Natl Food Res Inst |
冷凍生地耐性実用パン酵母
|
US5925544A
(en)
*
|
1996-11-18 |
1999-07-20 |
Novo Nordisk A/S |
Method of homologous recombination followed by in vivo selection of DNA amplification
|
EP1007732B1
(de)
|
1997-01-17 |
2006-07-26 |
Maxygen, Inc. |
EVOLUTION Prokaryotischer GANZER ZELLEN DURCH REKURSIVE SEQUENZREKOMBINATION
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US7148054B2
(en)
*
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
US6372453B1
(en)
|
1997-02-18 |
2002-04-16 |
Genetech, Inc. |
Neurturin receptor
|
US6025157A
(en)
*
|
1997-02-18 |
2000-02-15 |
Genentech, Inc. |
Neurturin receptor
|
US6777196B2
(en)
|
1997-02-18 |
2004-08-17 |
Genentech, Inc. |
Neurturin receptor
|
EP0981637B1
(de)
|
1997-03-14 |
2005-05-25 |
Biogen Idec Inc. |
Methode zur spezifischen integration von genen in säugetierzellen durch homologe rekombination, und vektoren zu deren durchführung
|
US5948653A
(en)
*
|
1997-03-21 |
1999-09-07 |
Pati; Sushma |
Sequence alterations using homologous recombination
|
US6172211B1
(en)
|
1997-07-11 |
2001-01-09 |
Boehringer Ingelheim International Gmbh |
Nucleic acid encoding tag7 polypeptide
|
CA2298412C
(en)
*
|
1997-07-23 |
2010-10-19 |
Roche Diagnostics Gmbh |
Identification of human cell lines for the production of human proteins by endogenous gene activation
|
US6548296B1
(en)
|
1997-07-23 |
2003-04-15 |
Roche Diagnostics Gmbh |
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
|
KR100641969B1
(ko)
|
1997-07-23 |
2006-11-06 |
로셰 디아그노스틱스 게엠베하 |
내인성 유전자 활성화에 의한 에리트로포이에틴의제조방법
|
PT1000154E
(pt)
|
1997-07-23 |
2007-03-30 |
Roche Diagnostics Gmbh |
Identificação de linhas celulares humanas para a produção de proteínas humanas por activação endógena de genes
|
BRPI9811031B8
(pt)
*
|
1997-07-23 |
2021-07-06 |
Roche Diagnostics Gmbh |
processo para preparar uma célula produtora de epo humana, processo para preparar epo humana, construção de dna para ativação de gene de epo endógeno, bem como plasmìdio.
|
US6897066B1
(en)
|
1997-09-26 |
2005-05-24 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
US7316923B1
(en)
|
1997-09-26 |
2008-01-08 |
Athersys, Inc. |
Compositions and methods for non-targeted activation of endogenous genes
|
KR20010024296A
(ko)
*
|
1997-09-26 |
2001-03-26 |
아더시스 인코포레이티드 |
벡터 구조체와 세포 dna의 비상동 재조합법에 의한내생 유전자 발현
|
ZA989497B
(en)
†
|
1997-10-20 |
2000-04-19 |
Roche Diagnostics Gmbh |
Positive-negative selection in homologous recombination.
|
EP2218730A1
(de)
|
1997-11-28 |
2010-08-18 |
Merck Serono Biodevelopment |
Genomsequenz von Chlamydia trachomatis sowie Polypeptide, Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
|
AU757930B2
(en)
*
|
1997-12-01 |
2003-03-13 |
Roche Diagnostics Gmbh |
Optimization of cells for endogenous gene activation
|
JPH11243944A
(ja)
*
|
1998-03-04 |
1999-09-14 |
Natl Food Res Inst |
製パン用乾燥耐性実用パン酵母
|
US6337072B1
(en)
|
1998-04-03 |
2002-01-08 |
Hyseq, Inc. |
Interleukin-1 receptor antagonist and recombinant production thereof
|
US6426191B1
(en)
|
1998-04-03 |
2002-07-30 |
Hyseq, Inc. |
Assays involving an IL-1 receptor antagonist
|
US6294655B1
(en)
|
1998-04-03 |
2001-09-25 |
Hyseq, Inc. |
Anti-interleukin-1 receptor antagonist antibodies and uses thereof
|
US6541623B1
(en)
|
1998-04-03 |
2003-04-01 |
Hyseq, Inc. |
Interleukin—1 receptor antagonist and uses thereof
|
US20020061522A1
(en)
|
2000-02-29 |
2002-05-23 |
Glucksmann Maria Alexandra |
1983, 52881, 2398, 45449, 50289, and 52872 novel G protein-coupled receptors and uses therefor
|
KR100795626B1
(ko)
|
1998-07-21 |
2008-01-17 |
코브라 바이오매뉴팩쳐링 피엘씨. |
도처에 있는 염색질 개방 요소(유씨오이)를 포함하는폴리뉴클레오티드
|
AU1447600A
(en)
*
|
1998-10-22 |
2000-05-08 |
Thomas J. Gardella |
Bioactive peptides and peptide derivatives of parathyroid hormone (pth) and parathyroid hormone-related peptide (pthrp)
|
US6773911B1
(en)
|
1998-11-23 |
2004-08-10 |
Amgen Canada Inc. |
Apoptosis-inducing factor
|
TW570977B
(en)
*
|
1998-12-07 |
2004-01-11 |
Li-Wei Hsu |
An expression system for producing recombinant human erythropoietin, method for purifying secreted human erythropoietin and uses thereof
|
DE19857609A1
(de)
|
1998-12-14 |
2000-06-15 |
Hannelore Ehrenreich |
Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
|
DE69940364D1
(de)
|
1999-05-18 |
2009-03-19 |
Dyax Corp |
Fab Fragmentbibliotheken und Verfahren für deren Verwendung
|
US6495360B1
(en)
*
|
1999-05-28 |
2002-12-17 |
Photogen, Inc. |
Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
|
US20050129669A1
(en)
*
|
1999-06-21 |
2005-06-16 |
Transkaryotic Therapies, Inc., A Massachusetts Corporation |
DNA construct for effecting homologous recombination and uses thereof
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
EP1222208B1
(de)
|
1999-09-29 |
2008-10-29 |
The General Hospital Corporation |
Parathyroid hormon (pth) polypeptidderivate
|
AU7734800A
(en)
*
|
1999-09-29 |
2001-04-30 |
General Hospital Corporation, The |
Polypeptide derivatives of parathyroid hormone (pth)
|
WO2001042442A2
(en)
|
1999-12-10 |
2001-06-14 |
Cytos Biotechnology Ag |
Activation of endogenous genes by genomic introduction of a replicon
|
EP1266016A2
(de)
*
|
2000-01-13 |
2002-12-18 |
Novozymes Biotech, Inc. |
Methoden zur produktion eines polypeptids durch benutzung einer verkrüppelten translationalen startseqeunz
|
EP1714661A3
(de)
|
2000-05-19 |
2012-03-14 |
The Center for Blood Research, INC. |
Verfahren zur Diagnose und Behandlung von hämostatischen Störungen durch Modulation der P-Selectin Aktivität
|
US6656700B2
(en)
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
US6686188B2
(en)
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
GB0018876D0
(en)
|
2000-08-01 |
2000-09-20 |
Applied Research Systems |
Method of producing polypeptides
|
EP2044839A3
(de)
*
|
2000-08-03 |
2009-07-01 |
Therapeutic Human Polyclonals, Inc. |
Herstellung von humanisierten Antikörpern in genveränderten Tieren
|
JP2003000268A
(ja)
|
2000-08-25 |
2003-01-07 |
Pfizer Prod Inc |
血管新生にかかわる疾患を診断および治療するための方法および組成物
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
AU2020902A
(en)
|
2000-12-06 |
2002-06-18 |
Robert J Hariri |
Method of collecting placental stem cells background of the invention
|
DE60144439D1
(de)
|
2000-12-20 |
2011-05-26 |
Hoffmann La Roche |
Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
|
JP4656814B2
(ja)
*
|
2000-12-20 |
2011-03-23 |
エフ.ホフマン−ラ ロシュ アーゲー |
エリスロポエチンコンジュゲート
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
ES2549161T3
(es)
|
2001-02-14 |
2015-10-23 |
Anthrogenesis Corporation |
Placenta post-parto de mamífero, su uso y células madre placentarias de la misma
|
IL157350A0
(en)
|
2001-02-14 |
2004-02-19 |
Anthrogenesis Corp |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
EP1925671A1
(de)
|
2001-06-06 |
2008-05-28 |
Bioriginal Food & Science Corp. |
Flax-(Linum usitatissimum L.)-Samenspezifische Promotoren
|
ATE404672T1
(de)
|
2001-06-06 |
2008-08-15 |
Bioriginal Food & Science Corp |
Samen-spezifische sequenzen aus flachs (linum usitatissimum l.)
|
WO2003009804A2
(en)
*
|
2001-07-23 |
2003-02-06 |
The General Hospital Corporation |
Conformationally constrained parathyroid hormone (pth) analogs
|
EP1575916B1
(de)
|
2001-08-31 |
2013-05-22 |
The Rockefeller University |
Phosphodiesteraseaktivität und regulation der durch phosphodiesterase-1-b vermittelten signalvermittlung im hirn
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
EP1455815A4
(de)
|
2001-12-19 |
2006-11-02 |
Millennium Pharm Inc |
Mitglieder der familie der humanen diacylglycerol-acyltransferase 2 (dgat2) und ihre verwendung
|
CN1296485C
(zh)
*
|
2002-01-17 |
2007-01-24 |
英国龙沙生物医药股份有限公司 |
能够产生蛋白质及能够在无谷氨酰胺的培养基上生长的谷氨酰胺营养缺陷型人类细胞
|
EP2186407A1
(de)
|
2002-02-13 |
2010-05-19 |
Anthrogenesis Corporation |
Embryoartige Stammzellen aus der Post Partum Plazenta von Säugetieren sowie Anwendungszwecke und Behandlungsverfahren, bei denen diese Zellen verwendet werden
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
US20060052320A1
(en)
*
|
2002-05-06 |
2006-03-09 |
Limin Li |
Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
|
WO2003100007A2
(en)
|
2002-05-24 |
2003-12-04 |
Schering-Plough Ltd. |
Eta-1 gene and methods for use
|
AU2003265525A1
(en)
*
|
2002-08-15 |
2004-03-19 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr7 genes
|
WO2004020582A2
(en)
*
|
2002-08-15 |
2004-03-11 |
Functional Genetics, Inc. |
Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes
|
US7459435B2
(en)
|
2002-08-29 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US20050037011A1
(en)
|
2002-11-21 |
2005-02-17 |
Jones Stephen N. |
Diagnosing and treating hematopoietic cancers
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
KR101042448B1
(ko)
|
2002-11-26 |
2011-06-16 |
안트로제네시스 코포레이션 |
세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
|
WO2004063356A2
(en)
*
|
2003-01-13 |
2004-07-29 |
Rao Mahendra S |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
US20050048041A1
(en)
*
|
2003-01-13 |
2005-03-03 |
Rao Mahendra S. |
Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
|
JP5568208B2
(ja)
|
2003-01-14 |
2014-08-06 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
癌治療感作物質
|
US8021833B2
(en)
|
2003-02-12 |
2011-09-20 |
Functional Genetics, Inc. |
Method for reducing HIV viral budding by administering a VPS28-specfic antibody that disrupts Gag-TSG101-VPS28 binding interactions
|
JP4334480B2
(ja)
*
|
2003-03-19 |
2009-09-30 |
ザ ジェネラル ホスピタル コーポレイション |
α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン
|
JP4871128B2
(ja)
|
2003-07-17 |
2012-02-08 |
ザ ジェネラル ホスピタル コーポレイション |
高次構造的に制約された副甲状腺ホルモン(pth)アナログ
|
US7287952B2
(en)
*
|
2003-07-23 |
2007-10-30 |
Lockheed Martin Corporation |
Feeder load automation system and method of use
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
AU2004277954A1
(en)
|
2003-09-29 |
2005-04-14 |
The Kenneth S Warren Institute, Inc. |
Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
|
CA2544365A1
(en)
|
2003-11-01 |
2005-05-12 |
Biovation, Ltd. |
Modified anti-cd52 antibody
|
PL1696947T3
(pl)
*
|
2003-12-19 |
2014-08-29 |
Hoffmann La Roche |
Zastosowanie erytropoetyny w leczeniu zaburzeń dystrybucji żelaza w przewlekłych chorobach zapalnych jelit
|
DK1709161T3
(da)
*
|
2004-01-19 |
2009-01-26 |
Nsgene As |
Humane terapeutiske celler, som udskiller nervevækstfaktor
|
US7510858B2
(en)
|
2004-08-02 |
2009-03-31 |
Janssen Pharmaceutica N.V. |
IRAK 1c splice variant and its use
|
US7893197B2
(en)
|
2004-08-25 |
2011-02-22 |
Janssen Pharmaceutica N.V. |
Relaxin-3 chimeric polypeptides and their preparation and use
|
EP2298897B1
(de)
|
2004-09-02 |
2013-08-14 |
Yale University |
Regulierung von Onkogenen durch mikro-RNAs
|
NZ554824A
(en)
|
2004-10-22 |
2010-10-29 |
Revivicor Inc |
Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
|
US7619007B2
(en)
|
2004-11-23 |
2009-11-17 |
Adamas Pharmaceuticals, Inc. |
Method and composition for administering an NMDA receptor antagonist to a subject
|
US8058291B2
(en)
|
2005-04-06 |
2011-11-15 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of CNS-related conditions
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
AU2005325768A1
(en)
*
|
2005-01-25 |
2006-08-03 |
Apollo Life Sciences Limited |
Molecules and chimeric molecules thereof
|
EP2365086A1
(de)
|
2005-02-09 |
2011-09-14 |
Bioriginal Food & Science Corporation |
Neuartige Omega-3-Fettsäure-Desaturase-Familienmitglieder und Verwendungen davon
|
US8354384B2
(en)
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
CN104138392A
(zh)
|
2005-10-13 |
2014-11-12 |
人类起源公司 |
使用胎盘干细胞的免疫调节
|
US7767420B2
(en)
|
2005-11-03 |
2010-08-03 |
Momenta Pharmaceuticals, Inc. |
Heparan sulfate glycosaminoglycan lyase and uses thereof
|
US8014957B2
(en)
|
2005-12-15 |
2011-09-06 |
Fred Hutchinson Cancer Research Center |
Genes associated with progression and response in chronic myeloid leukemia and uses thereof
|
CA2633775A1
(en)
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
EP2471907B1
(de)
|
2005-12-29 |
2018-09-26 |
Celularity, Inc. |
Plazentastammzellenpopulationen
|
DE102006004008A1
(de)
|
2006-01-27 |
2007-08-02 |
Hannelore Prof. Dr. Dr. Ehrenreich |
Verfahren zur Behandlung und/oder Prophylaxe von Multipler Sklerose, sowie Verwendung von Erythropoietin zur Herstellung eines Arzneimittels zur intermittierenden Behandlung und/oder intermittierenden Prophylaxe von Multipler Sklerose
|
EP2650305A1
(de)
|
2006-03-24 |
2013-10-16 |
Biogen Idec Hemophilia Inc. |
PC5 als Faktor-IX-Propeptid-verarbeitendes Enzym
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
EP2236623A1
(de)
|
2006-06-05 |
2010-10-06 |
Cancer Care Ontario |
Feststellung des Risikos für Kolorektalkrebs
|
US8143374B2
(en)
*
|
2006-08-04 |
2012-03-27 |
The General Hospital Corporation |
Polypeptide derivatives of parathyroid hormone (PTH)
|
PL2054074T3
(pl)
|
2006-08-04 |
2015-03-31 |
Prolong Pharmaceuticals Llc |
Zmodyfikowana erytropoetyna
|
PE20081216A1
(es)
|
2006-09-01 |
2008-09-04 |
Therapeutic Human Polyclonals Inc |
Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
|
US8562972B2
(en)
|
2006-10-23 |
2013-10-22 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
US7745148B2
(en)
|
2006-10-30 |
2010-06-29 |
Functional Genetics, Inc. |
Random homozygous gene perturbation to enhance antibody production
|
EP2915537A3
(de)
|
2007-02-12 |
2015-10-28 |
Anthrogenesis Corporation |
Behandlung von Infektionskrankheiten mithilfe von Plazenta-Stammzellen
|
EP2079839A4
(de)
|
2007-03-05 |
2009-11-18 |
Cancer Care Ontario |
Abschätzung des kolorektalkarzinomrisikos
|
CA2687079A1
(en)
|
2007-05-11 |
2008-11-20 |
The Trustees Of The University Of Pennsylvania |
Methods of treatment of skin ulcers
|
EA200971050A1
(ru)
|
2007-05-11 |
2010-06-30 |
Томас Джефферсон Юниверсити |
Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений
|
CA2691539C
(en)
|
2007-06-21 |
2014-08-26 |
Angelica Therapeutics, Inc. |
Modified toxins
|
AR067536A1
(es)
|
2007-07-17 |
2009-10-14 |
Hoffmann La Roche |
Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
|
CL2008002053A1
(es)
|
2007-07-17 |
2009-05-22 |
Hoffmann La Roche |
Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
|
WO2009010107A1
(en)
|
2007-07-19 |
2009-01-22 |
Hannelore Ehrenreich |
Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
|
BRPI0814962B8
(pt)
|
2007-08-01 |
2021-05-25 |
Chugai Pharmaceutical Co Ltd |
métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
US20120100143A1
(en)
|
2007-09-24 |
2012-04-26 |
Yung-Fu Chang |
Immunogenic proteins from genome-derived outer membrane of leptospira and compositions and methods based thereon
|
US8263065B2
(en)
|
2007-09-28 |
2012-09-11 |
Anthrogenesis Corporation |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
US8501449B2
(en)
|
2007-12-04 |
2013-08-06 |
Proteon Therapeutics, Inc. |
Recombinant elastase proteins and methods of manufacturing and use thereof
|
EP2570496A3
(de)
|
2008-01-02 |
2013-03-27 |
Suregene Llc |
Genetische Marker für Geisteskrankheiten
|
EP2581454B1
(de)
|
2008-01-17 |
2015-09-16 |
Suregene LLC |
Genetische Marker von Geisteskrankheiten
|
JP2011515078A
(ja)
*
|
2008-03-01 |
2011-05-19 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
SPARC特異的miRNAを使用する、治療、診断、及び拮抗物質発見方法
|
JP5670755B2
(ja)
|
2008-03-12 |
2015-02-18 |
ザ ロックフェラー ユニバーシティ |
翻訳プロファイリング及び分子表現型解析のための方法及び組成物
|
WO2009137660A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
WO2010021714A2
(en)
|
2008-08-20 |
2010-02-25 |
Anthrogenesis Corporation |
Improved cell composition and methods of making the same
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2344672B8
(de)
|
2008-09-25 |
2014-12-24 |
SureGene LLC |
Genetische marker zur optimierung einer schizophreniebehandlung
|
EP2342226B1
(de)
|
2008-09-26 |
2016-06-22 |
Dana-Farber Cancer Institute, Inc. |
Menschliche pd1-, pd-l1- und pd-l2-antikörper sowie anwendungen dafür
|
US8110185B2
(en)
*
|
2008-10-03 |
2012-02-07 |
St. Michael's Hospital |
Method for preventing and treating cardiovascular diseases with BRCA1
|
US20100120063A1
(en)
*
|
2008-10-10 |
2010-05-13 |
Discoverx Corporation |
GPCR Arrestin Assays
|
ES2548377T3
(es)
|
2008-10-27 |
2015-10-16 |
Revivicor, Inc. |
Ungulados inmunodeprimidos
|
JP2012508014A
(ja)
|
2008-11-04 |
2012-04-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Crhr2ペプチド作動薬及びその使用
|
MX2011005229A
(es)
|
2008-11-19 |
2011-06-16 |
Anthrogenesis Corp |
Celulas adherentes derivadas del amnios.
|
US8492133B2
(en)
|
2009-01-20 |
2013-07-23 |
Ramot At Tel Aviv University, Ltd. |
MIR-21 promoter driven targeted cancer therapy
|
US8530629B2
(en)
|
2009-01-30 |
2013-09-10 |
Ab Biosciences, Inc. |
Lowered affinity antibodies and uses therefor
|
US8211655B2
(en)
*
|
2009-02-12 |
2012-07-03 |
Discoverx Corporation |
Wild-type receptor assays
|
AU2010315131A1
(en)
|
2009-11-04 |
2012-05-31 |
Janssen Pharmaceutica Nv |
Method for treating heart failure with stresscopin-like peptides
|
CA2778953C
(en)
|
2009-11-13 |
2020-01-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
|
WO2011062997A2
(en)
|
2009-11-17 |
2011-05-26 |
Musc Foundation For Research Development |
Human monoclonal antibodies to human nucleolin
|
CA2785020C
(en)
|
2009-12-22 |
2020-08-25 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
US9121007B2
(en)
|
2010-01-26 |
2015-09-01 |
Anthrogenesis Corporatin |
Treatment of bone-related cancers using placental stem cells
|
CN102971342B
(zh)
|
2010-01-28 |
2016-08-03 |
Ab生物科学公司 |
亲和力降低的新抗体和制备所述抗体的方法
|
US10745467B2
(en)
|
2010-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
|
US20150231215A1
(en)
|
2012-06-22 |
2015-08-20 |
Randolph J. Noelle |
VISTA Antagonist and Methods of Use
|
US9631018B2
(en)
|
2010-03-26 |
2017-04-25 |
The Trustees Of Dartmouth College |
Vista regulatory T cell mediator protein, vista binding agents and use thereof
|
CN102933703A
(zh)
|
2010-04-07 |
2013-02-13 |
人类起源公司 |
使用胎盘干细胞的血管生成
|
CN103002906B
(zh)
|
2010-05-13 |
2017-12-29 |
总医院有限公司 |
甲状旁腺激素类似物及其应用
|
CN103097520B
(zh)
|
2010-07-13 |
2017-12-05 |
人类起源公司 |
产生自然杀伤细胞的方法
|
US8862410B2
(en)
|
2010-08-02 |
2014-10-14 |
Population Diagnostics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
PL2616101T3
(pl)
|
2010-09-14 |
2015-01-30 |
Hoffmann La Roche |
Sposób oczyszczania pegylowanej erytropoetyny
|
AU2011336467A1
(en)
|
2010-12-01 |
2013-07-04 |
Spinal Modulation, Inc. |
Agent delivery systems for selective neuromodulation
|
EP2471543A1
(de)
|
2010-12-02 |
2012-07-04 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Toleranzinduktion oder Immunsuppression zur Verhinderung von insbesondere Transplantat-Wirt-Reaktion (GvHD) durch kurzzeitige Vorinkubation von transplantierten Zellsuspensionen, Geweben oder Organen, die mit Liganden zu Zelloberflächenmolekülen beschichtet sind
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
PT2714059T
(pt)
|
2011-06-01 |
2019-02-04 |
Celularity Inc |
Tratamento da dor utilizando células estaminais da placenta
|
US8759313B2
(en)
|
2011-08-03 |
2014-06-24 |
The Charlotte-Mecklenburg Hospital Authority |
Treatment of fibrosis using microRNA 19b
|
US20140227293A1
(en)
|
2011-06-30 |
2014-08-14 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
WO2013067451A2
(en)
|
2011-11-04 |
2013-05-10 |
Population Diagnostics Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
WO2013120018A1
(en)
|
2012-02-09 |
2013-08-15 |
Population Diagnostics, Inc. |
Methods and compositions for screening and treating developmental disorders
|
JP6411218B2
(ja)
|
2012-02-15 |
2018-10-24 |
ノヴォ ノルディスク アー/エス |
骨髄細胞で発現されるトリガー受容体1(trem−1)に結合し、それを遮断する抗体
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
EP3401399B1
(de)
|
2012-03-02 |
2020-04-22 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
WO2013152011A1
(en)
|
2012-04-02 |
2013-10-10 |
Ab Biosciences, Inc. |
Novel human control antibodies and uses therefor
|
EP3839050A3
(de)
*
|
2012-04-18 |
2021-09-29 |
The Board of Trustees of the Leland Stanford Junior University |
Disruptionsfreies gen-targeting
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US9890215B2
(en)
|
2012-06-22 |
2018-02-13 |
King's College London |
Vista modulators for diagnosis and treatment of cancer
|
AU2013290102B2
(en)
|
2012-07-13 |
2018-11-15 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP2892558B1
(de)
|
2012-09-07 |
2019-04-10 |
The Trustees Of Dartmouth College |
Vista-modulatoren zur diagnose und behandlung von krebs
|
WO2014043519A1
(en)
|
2012-09-14 |
2014-03-20 |
Population Diagnostics Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
EP2900835A4
(de)
|
2012-09-27 |
2016-05-11 |
Population Diagnotics Inc |
Verfahren und zusammensetzungen zum screening und zur behandlung von entwicklungsstörungen
|
CN103864913A
(zh)
|
2012-12-18 |
2014-06-18 |
联亚生技开发股份有限公司 |
重组蛋白
|
CN115137753A
(zh)
|
2013-02-05 |
2022-10-04 |
细胞结构公司 |
来自胎盘的自然杀伤细胞
|
WO2014168711A1
(en)
|
2013-03-13 |
2014-10-16 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
CA2902905A1
(en)
|
2013-03-15 |
2014-09-25 |
Claude Geoffrey Davis |
Modified toxins
|
EP2970420A4
(de)
|
2013-03-15 |
2016-08-17 |
Apotex Inc |
Erhöhte flüssigkeitsformulationsstabilität von erythropoietin-alpha durch aufreinigungsverarbeitung
|
US10294295B2
(en)
|
2013-11-27 |
2019-05-21 |
Inis Biotech Llc |
Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment
|
KR102344991B1
(ko)
|
2013-12-24 |
2021-12-28 |
잔센파마슈티카엔.브이. |
항-vista 항체 및 단편
|
US11014987B2
(en)
|
2013-12-24 |
2021-05-25 |
Janssen Pharmaceutics Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
AU2015231231B2
(en)
|
2014-03-21 |
2021-09-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
MX2016016310A
(es)
|
2014-06-11 |
2017-10-20 |
A Green Kathy |
Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
|
US10724096B2
(en)
|
2014-09-05 |
2020-07-28 |
Population Bio, Inc. |
Methods and compositions for inhibiting and treating neurological conditions
|
JP6841753B2
(ja)
|
2014-09-15 |
2021-03-10 |
ザ チルドレンズ メディカル センター コーポレーション |
ヒストンh3−リジントリメチル化を除去することによって体細胞核移入(scnt)効率を増加させるための方法および組成物
|
EP3015475A1
(de)
|
2014-10-31 |
2016-05-04 |
Novartis AG |
Säugetierzellen zur Expression von Cytomegalovirus-Antigenen
|
EP3226900A4
(de)
|
2014-12-05 |
2018-09-19 |
Immunext, Inc. |
Identifizierung von vsig8 als vermeintlicher vista-rezeptor und dessen verwendung zur herstellung von vista/vsig8-modulatoren
|
EP3031822A1
(de)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus-Antigene
|
EP3048114A1
(de)
|
2015-01-22 |
2016-07-27 |
Novartis AG |
Cytomegalovirus-Antigene und Verwendungen davon
|
WO2016118832A1
(en)
|
2015-01-22 |
2016-07-28 |
University Of Massachusetts |
Cancer immunotherapy
|
EP3047856A1
(de)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv-antigene und ihre verwendungen
|
CA2990360C
(en)
|
2015-06-24 |
2024-02-13 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
TWI756204B
(zh)
|
2016-02-12 |
2022-03-01 |
比利時商楊森製藥公司 |
抗vista抗體及片段、其用途及鑑定其之方法
|
US11357849B2
(en)
|
2016-03-07 |
2022-06-14 |
Musc Foundation For Research Development |
Anti-nucleolin antibodies
|
EP3448412A4
(de)
|
2016-04-15 |
2020-03-25 |
Immunext Inc. |
Anti-human-vista-antikörper und verwendung davon
|
SI3484911T1
(sl)
|
2016-07-15 |
2021-02-26 |
F. Hoffmann-La Roche Ag |
Postopek za čiščenje PEGiliranega eritropoetina
|
WO2018144807A2
(en)
*
|
2017-02-02 |
2018-08-09 |
Massachusetts Institute Of Technology |
Engineered yeast as a method for bioremediation
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
KR102497097B1
(ko)
|
2017-12-29 |
2023-02-06 |
에프. 호프만-라 로슈 아게 |
페길화 단백질 조성물의 제공 방법
|
SG11202005990RA
(en)
|
2017-12-29 |
2020-07-29 |
Hoffmann La Roche |
Process for providing pegylated protein composition
|
KR102500631B1
(ko)
|
2017-12-29 |
2023-02-15 |
에프. 호프만-라 로슈 아게 |
페길화 단백질 조성물의 제공 방법
|
FI3625368T3
(fi)
|
2018-08-08 |
2023-01-13 |
|
Menetelmiä john cunningham -viruksen aiheuttaman progressiivin multifokaalin leukoenkefalopatian kehittymisen riskin arviointiin geneettisellä testauksella
|
US20230201334A1
(en)
|
2019-07-24 |
2023-06-29 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
WO2022159414A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Rochester |
Erythropoietin for gastroinfestinal dysfunction
|
WO2023144665A1
(en)
|
2022-01-28 |
2023-08-03 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|